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Abstract
Functional imaging can provide a level of quantification that is not possible in what might be termed traditional high-
content screening. This is due to the fact that the current state-of-the-art high-content screening systems take the approach
of scaling-up single cell assays, and are therefore based on essentially pictorial measures as assay indicators. Such
phenotypic analyses have become extremely sophisticated, advancing screening enormously, but this approach can still be
somewhat subjective. We describe the development, and validation, of a prototype high-content screening platform that
combines steady-state fluorescence anisotropy imaging with fluorescence lifetime imaging (FLIM). This functional approach
allows objective, quantitative screening of small molecule libraries in protein-protein interaction assays. We discuss the
development of the instrumentation, the process by which information on fluorescence resonance energy transfer (FRET)
can be extracted from wide-field, acceptor fluorescence anisotropy imaging and cross-checking of this modality using
lifetime imaging by time-correlated single-photon counting. Imaging of cells expressing protein constructs where eGFP and
mRFP1 are linked with amino-acid chains of various lengths (7, 19 and 32 amino acids) shows the two methodologies to be
highly correlated. We validate our approach using a small-scale inhibitor screen of a Cdc42 FRET biosensor probe expressed
in epidermoid cancer cells (A431) in a 96 microwell-plate format. We also show that acceptor fluorescence anisotropy can be
used to measure variations in hetero-FRET in protein-protein interactions. We demonstrate this using a screen of inhibitors
of internalization of the transmembrane receptor, CXCR4. These assays enable us to demonstrate all the capabilities of the
instrument, image processing and analytical techniques that have been developed. Direct correlation between acceptor
anisotropy and donor FLIM is observed for FRET assays, providing an opportunity to rapidly screen proteins, interacting on
the nano-meter scale, using wide-field imaging.
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Introduction
High-content imaging can be defined broadly as the use of
automated fluorescence microscopy with minimal user interven-
tion, for screening of small-molecule libraries and interfering
RNAs [1]. This is as opposed to high-throughput screening which
concentrates on screening against huge libraries of compounds at
high-speed; examples are flow cytometry [2,3] or in-vitro assays
using microplate-reader devices [4]. In recent years, specific in-
strumentation and software packages have been developed com-
mercially for high-content screening. There are confocal, point
scanning systems such as Opera (Perkin Elmer), ImageXpress
ULTRA (Molecular Devices, Union City, USA) and the IsoCyte
(Blueshift Biotechnologies, Sunnydale, CA, USA) and wide-field
systems such as the ScanˆR (Olympus Soft Imaging Solutions,
Germany). These are, for the most part, essentially microscopes
which have been re-engineered to achieve a small footprint and
full automation. Such systems allow phenotyping assays to be
scaled-up to large numbers putting a huge burden on image
analysis [5,6]. Providing quantitative phenotypic information is
extremely difficult [7,8] and can be subjective.
The adoption of high-content screening by imaging puts the
assay in a more physiological context by giving spatial in-
formation: a cell based assay can directly reflect the complexity
of the myriad signalling pathways [9]. Many of these signalling
cascades have been extensively investigated and the relationships
between proteins have been partially delineated using biochem-
ical techniques. Microscopical techniques, coupled with immuno-
cytochemical methods allow us to preserve and image the relative
localisation of multiple signalling molecules in cellular compart-
ments under quiescent or stimulated conditions. Whilst a degree
of localisation of proteins is conferred using these techniques, the
spatial resolution afforded by conventional, far-field microscopy
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is insufficient to resolve the specific inter-relationship between
individual protein complexes occurring on the nanometer length
scale. Measurement of the near-field localisation of protein
complexes may be achieved by the detection of Fo¨rster resonant
energy transfer (FRET) between protein-conjugated fluorophores
[10]. FRET is a non-radiative, dipole-dipole coupling process
whereby energy from an excited donor fluorophore is transferred
to an acceptor fluorophore in close proximity [11,12,13]. Clearly
it would be desirable to combine the throughput of high content
imaging with a quantitative read-out such as that generated in
FRET assays.
In this paper we propose the use of two functional imaging
modalities to provide quantitative information for high-content
screening of protein-protein interactions using FRET. We use
fluorescence acceptor anisotropy [14,15] as a fast, first-pass screen,
and combine this with fluorescence lifetime imaging [16,17,18] as
a cross-checking methodology. The comparative strengths of the
two techniques are discussed and the complementary nature of the
metrics is elucidated. The first model system we test is the ‘Ras and
interacting protein chimeric unit’ (Raichu), a Rho-GTPase FRET
biosensor system kindly provided by Matsuda and co-workers
[19,20], and modified to express an eGFP [21] and an mRFP1
[22] acceptor making them suitable for imaging by fluorescence
lifetime microscopy (FLIM) [23,24]. Having previously applied
acceptor anisotropy for dynamic imaging of such a biosensor in T-
cells [25] we extend this assay to a high content screening format
and use the Cdc42 version of the Raichu biosensor to demonstrate
how this could be achieved. The 1:1 stoichiometry makes Raichu
particularly useful in this context since the analysis of FRET is
made simpler by removing the effects of the relative concentra-
tion of the donor and acceptor molecules which occurs in dual
expression systems [26]. We assay performance against a set of
FRET standards consisting of eGFP and mRFP1 separated by
amino-acid sequences of varying length (similar to those developed
by Vogel and co-workers [27]). We use the test constructs to show
that FRET imaged using acceptor fluorescence anisotropy and
FLIM are highly correlated. This allows us to calibrate images
generated using fluorescence anisotropy.
In a second model system we demonstrate how the technique
can be applied to protein dimerization relying on the expression of
two variants of the same protein with different fluorescent tags. In
particular, we use cell lines stably expressing the chemokine
receptor CXCR4, which is tagged to either monomeric eGFP or
monomeric TagRFP [28]. CXCR4 receptor dimerization increas-
es upon stimulation of the cells with the native ligand CXCL12
(formerly also known as SDF-1alpha) [29]. In a mock high content
screen we exposed these cells to variety of small molecule com-
pounds known to be effective inhibitors of several different cellular
pathways. Using high-content FRET imaging, we were able to
correctly categorize all small molecule compounds to either be
CXCR4 inhibitors or not.
This paper represents the first demonstration of FRET effi-
ciency measured by acceptor anisotropy and directly correlated
with donor FLIM measurement of the same protein-protein
interaction. The techniques presented here support the notion that
not only trivial on/off FRET assays (such as DEVD substrate
cleavage for caspase activity sensors) but also complex protein-
protein interaction assays can be reliably sensed by acceptor
FRET anisotropy. In combination these two techniques allows us
to demonstrate that fluorescence acceptor anisotropy can be used
as a fast, first-pass to screen FRET interactions which can then
be cross-checked and accurately quantified using FLIM and to
robustly identify false positives.
Functional Imaging
FRET determination by acceptor anisotropy. A full
discussion of the relationship between FRET and fluorescence
anisotropy was described in detail elsewhere [14,30,31,32]. Briefly,
a measurement of the depolarisation of fluorescence of a molec-
ular species can provide a sensitive measure of orientation, mo-
bility and energy migration processes. In fluorescence anisotropy
imaging contrast is obtained by monitoring the extent of po-
larisation retained by a population of molecules following exci-
tation. It is an extremely versatile methodology and can be
implemented in steady-state or time-resolved measurements and in
wide-field or confocal microscopes. In a system of homogeneous
molecules fluorescence anisotropy provides the only means by
which self-interaction, (homo-FRET) can be measured [33]. In a
hetero-FRET system it has been shown by us, and others, that
fluorescence anisotropy can provide a high dynamic range method
for monitoring energy transfer [15]. Fluorescence lifetime
measurements of donor molecules undergoing FRET reveal a
reduction in the radiative decay time since energy transfer
provides an additional mechanism by which the molecules can
return to their ground state. A reduction in fluorescence lifetime
directly results in an increase in the polarisation, and therefore
anisotropy, of the donor molecules in a hetero-FRET system as







Here r0 is the limiting (maximum) anisotropy, r the measured
anisotropy, t the fluorescence lifetime and h, the rotational
correlation time. However, the dynamic range of donor po-
larisation as a result of FRET is limited. Conversely, a low value of
anisotropy of acceptor molecules is observed. The highly-polarised
nature of the donor and the unconstrained orientation of the
acceptor molecules results in an apparently highly depolarised
acceptor population. This technique provides good dynamic range
in a system where the fundamental anisotropy (i.e. in the absence
of FRET) is high. Fluorescent proteins prove to be particularly
good candidates since they have rotational correlation times that
far exceed their fluorescence lifetime as they are large, sterically
hindered molecules. Since the donors do not rotationally diffuse
significantly before emitting a photon this results in maintenance
of the initial photoselection of the dipoles to the polarised
excitation.
Quantification of the acceptor anisotropy is analogous to
sensitized emission FRET and was proposed by Jares-Erijman









Here sa (sd) is the acceptor (donor) extinction coefficient at the
wavelength of excitation; r0 is the fundamental anisotropy (in the
absence of FRET) and r is the measured anisotropy.
Fluorescence lifetime imaging: donor FRET. In FLIM
imaging contrast is generated by spatial variations in the excited
singlet state lifetime of the observed fluorescent species. The
sensitivity of this approach is such that FLIM microscopy has
found wide-spread use in fields as diverse as pH sensing [35],
viscosity and refractive index sensing [36,37] and glucose
monitoring [38]. FLIM also provides a means to measure FRET
since the excited state population of the donor becomes depleted
reducing both the fluorescence intensity and fluorescence lifetime
of the donor. The advantage of using donor fluorescence lifetime
Multi-Functional Imaging in High-Content Screening
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to detect FRET is that the method is independent of fluorophore
concentration, donor-acceptor stoichiometry and optical path
length and is therefore well suited to studies in intact cells
[39,40,41,42,43]. Combined with confocal or multiphoton tech-
niques to examine the localisation of effects in cellular com-
partments, FRET/FLIM allows us to determine populations of
interacting protein species on a point-by-point basis at each resolved
voxel in the cell [44,45,46,47,48,49]. The use of ‘ensemble’ FRET/
FLIM techniques to probe protein-protein interactions in intact cells
is now an established technique [50,51,52]. We and others have
adapted the FLIM-based protein-protein interaction assays to
directly monitor post-translational modifications (PTMs) ofproteins
(such as phosphorylation by PKC [53,54,55], ubiquitination [56]
and sumoylation [57,58]) in live and fixed cells.
The measurement of fluorescence lifetime can directly inform









Here tD (tDA) is the fluorescence lifetime of the donor in the
absence (presence) of the acceptor. R0 is the distance at which
the FRET efficiency is 50% (the Fo¨rster radius) and r represents
the intermolecular distance.
FLIM imaging of biological samples is currently undertaken using
two distinct methodologies; a sequential single point measurement
typically using the time-correlated single-photon counting tech-
nique (TCSPC) (but also frequency domain [59]) or a massively
parallel detection using wide-field illumination and a gated or
modulated intensified camera. The former approach, whilst offering
excellent signal-to-noise and accurate lifetime determination suffers
from a lack of speed due to both a requirement to scan and to
integrate a sufficient number of photons to achieve an accurate fit to
the data. In contrast, wide-field FLIM as exemplified by French and
co-workers [60] or Bastiaens [61] (time and frequency domain
respectively) is fast but suffers from both poor spatial resolution (due
to the quality of available image intensifiers) and may be subject to
artefactual errors in lifetime determination. In order to increase
speed in laser scanning systems whilst maintaining a sufficient
signal-to-noise ratio for FLIM applications, a number of multi-beam
methodologies have been developed which enable parallelisation of
image acquisition up to the maximum count rate of the detection
electronics [62].
Results
Robustness and Sensitivity Testing
The sensitivity and robustness of the fluorescence anisotropy
detection was characterised using a 96-well microlate containing
Rhodamine B dissolved in solutions with varying concentrations of
glycerol. Figure 1A, shows the full data range (a portion of data is
given in the inset) from an experimental measurement of the
fluorescence anisotropy. Since Rhodamine B is a small molecule,
changing the concentration of glycerol allows the mobility, and
therefore the anisotropy to be continuously varied. These data
illustrate the sensitivity and repeatability achieved. Each image in
the sequence is acquired from individual wells the microplate with
the concentration of glycerol being varied in each of the eight rows
of the plate. The sensitivity is such that a change in anisotropy of
60.004 is clearly and repeatedly detected.
The FLIM component of the microscope was tested by measuring
the fluorescence lifetime in each well of the same Rhodamine B
sample (as shown in figure 1B). Although the fluorescence anisot-
ropy is dramatically altered by varying the glycerol content, the
fluorescence lifetime remains constant. The graph shows that there
is little variation in the decay time across the plate when fitted to a
mono-exponential function.
FRET Standards
FRET standards, similar to those described by Vogel and co-
workers [27], consisting of eGFP linked to mRFP1 by amino acid
chains of varying lengths (7, 19, and 32 amino acids) are used both
as a means to correlate the acceptor anisotropy and donor lifetime
measurements, and to provide positive and negative controls in
screening data. Figure 2 shows example images of 293T cells
Figure 1. Demonstration of sensitivity and repeatability of
fluorescence anisotropy and fluorescence lifetime imaging. (A)
Anisotropy measurements of rhodamine B dissolved in varying
concentrations of water and glycerol. The concentration of glycerol is
used as a way of tuning the rotational diffusion, and therefore
anisotropy, of the fluorophore. Any increasing percentage of glycerol
reduces the mobility of the fluorophore molecules thereby increasing
the fluorescence anisotropy. Differences of the order of 0.004 are easily
and repeatedly measured. (B) Fluorescence lifetime measurements of
the same rhodamine B sample. The concentration of glycerol has no
effect on the lifetime. It is clear that the measurement is highly
repeatable.
doi:10.1371/journal.pone.0033231.g001
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transiently transfected with the 7AA and 32AA constructs and
plated onto coverglass (see Materials and Methods). Figure 2A
shows intensity images from the wide-field and laser scanning
components of the microscope. Figure 2B illustrates the correlation
between the anisotropy and lifetime imaging techniques. Although
there is some cell to cell heterogeneity in the images, due to a
variation in transfection efficiency across the sample, it is clear that
the anisotropy and lifetime images provide identical contrast.
The data for all three FRET standards in both modalities are
summarized in figure 3A. In the FLIM data an increasing FRET
efficiency is observed with a decrease in linker length with values of
23%, 27% and 33% measured for the 32AA, 19AA and 7AA
constructs respectively. A corresponding, and correlated trend (see
figure S1) is seen in the anisotropy data. Despite the fact that the
photophysics of the hetero-FRET interaction limits the dynamic
range of the measurement, the sensitivity of the technique is such
that variations in anisotropy, which directly result from a
difference in the rate of energy transfer, can be observed with
identical contrast to that observed in the FLIM data.
Histograms from the representative anisotropy and lifetime
images in Figure 2B are shown figure 3B. Despite the het-
erogeneity present in the images a clear distinction can be seen in
the histograms. The GFP histogram for the anisotropy data is
somewhat wider than those for the 7AA and 32AA constructs since
these data were calculated from GFP bleed-through in the RFP
channel. The low number of collected photons results in a broad
histogram. These data were converted to FRET efficiency using
equation (2) for the anisotropy and using equation (3) for the
lifetime data (figure 3C).
High-Content Screening
Small molecule inhibitor screening: CDC42 Riachu
Biosensor. Figure 4A shows examples of acceptor flu-
orescence anisotropy of the Cdc42-Raichu biosensor probe
when stably expressed in the A431 human epidermoid cancer
cell line and seeded in a 96 well microplate. Upon binding of GTP
to Cdc42, the biosensor changes conformation bringing the donor
eGFP in close proximity to the acceptor mRFP1 resulting in a
reduction of the donor fluorescence lifetime and an apparent
depolarisation of the acceptor emission. One image per well was
acquired when exciting the acceptor directly and then indirectly
via the eGFP donor. This provides a means to characterise the
level of heterogeneity in the baseline measurement of acceptor
anisotropy and to test the ability of the microscope to measure
sensitised emission. We can also test the level of bleed-through of
donor emission into the acceptor channel, and vice versa. The
data points in the graph plotted in figure 4B summarise the
acceptor anisotropy when directly excited and when excited
through energy transfer which plots fluorescence anisotropy as
function of the image area used in the calculation. The instrument
operates in an automated, unsupervised mode where the
coordinates for image acquisition are generated by capturing the
positions of seven separate points across the plate; the software
produces a grid of (x, y) coordinates and a polynomial function is
used to generate the z-position (or focal plane). This is necessary
due to the non-linear topography of the cover-glass of the multi-
well plate. These (x, y, z) coordinates are visited in turn and a
software autofocus routine is used to provide a fine adjustment of
the focal plane prior to acquiring an image. Currently, we use the
image area above a given intensity threshold as a percentage of the
total imaged area as a means to exclude empty images from
subsequent analysis. After removal of such outliers, we measure a
mean value across the 96-well plate of (0.26360.006) and
(0.12560.009) when excited directly and via the donor (by
energy transfer) respectively (figure 4B).
Figure 4C and 4D shows the fluorescence anisotropy and
lifetime of a selection of biosensor constructs as well as the three
FRET standards. All constructs were expressed in 293T cells
which were then plated in 24 wells of a 96-well microplate and
fixed as described in Materials and Methods. This experiment
illustrates the process of screening using functional imaging. Here
we measure both the anisotropy and the fluorescence lifetime for
four regions of interest for each of the 24 wells giving eight
different conditions with three repeats of each condition. All the
information required to calculate the acceptor anisotropy is
captured in 800 ms CCD exposures and averaging over three
frames. With an autofocus time of 6 seconds and the time taken to
move the microscope stage between the coordinates the epi-
fluorescence images from which the anisotropy is calculated are
acquired within 17 minutes. The fluorescence lifetime images by
comparison require three minutes to capture a single frame and
therefore acquiring all 108 images takes 5.4 hours.
We tested our methodology by studying effect of tyrosine kinase
inhibitors (TKI) on Cdc42 using the Raichu biosensor system.
Figure 5 shows data from 50 wells of 96 well microplate seeded
with A431 epidermoid cancer cells. In three wells per row (total of
15 wells), the cells were transiently transfected with FRET
standard constructs (data for 19AA and 32AA shown) and four
wells per row (total of 20 wells) contained Cdc42-Raichu. Three
rows of the plate were treated with a different TKI, one row
remained untreated and one row was control treated with DMSO
(the solvent in which the TKIs are dissolved). Five images per well
in each modality were recorded. The wide-field images were
recorded using 800 ms exposures and three frames were averaged
Figure 2. Imaging of FRET standard constructs expressed in
293T cells. (A) Intensity images from the wide-field and laser scanning
modalities. (B) Functional images for GFP, 32AA and 7AA standards. This
amply demonstrates the correlation between the two measurement
techniques and the sensitivity in determining changes in FRET
efficiency. (Scale bars represent 50 mm.)
doi:10.1371/journal.pone.0033231.g002
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to provide adequate signal-to-noise for calculation of senstised
emission anisotropy. All the information required to calculate the
fluorescence anisotropy was obtained in around 43 minutes
(including the time taken for the autofocus routine to run). The
FLIM data required 3 minutes per image and a total time of
12.5 hours for the entire data set.
Small molecule inhibitor screening: Chemokine receptor
dimerisation. The chemokine receptor CXCR4 is a member
of the transmembrane domain G protein-coupled receptor su-
perfamily (GPCRs) which is specific for the CXCL12 ligand.
CXCR4 has been shown to act as a co-receptor for HIV [63] and
is highly expressed in human breast cancer cells [64]. CXCR4 is
an excellent model system since it forms homo-dimers during
CXCL12 stimulated internalisation, a process which can be
visualised using FRET [65,66]. Prior to stimulation CXCR4 is
located at the cell membrane and does not undergo dimerisation.
We used a rat breast cancer cell line (MTLn3E) stably co-
expressing CXCR4-eGFP and CXCR4-TagRFP, generated by
retroviral infection and subsequent single cell sorting by FACS to
obtain clonal populations with defined ratios of the two differently
tagged receptor molecules. Upon ligand treatment a mixed
population of homo- (CXCR4-eGFP only and CXCR4-TagRFP
only) and hetero-dimers (CXCR4-eGFP and CXCR4-TagRFP)
are to be expected but here we select the hetero-FRET sub-
population by means of our chosen measurement methods. In
order to increase the probability of measuring this sub-population
we used a clone with an acceptor (CXCR4-TagRFP) to donor
(CXCR4-eGFP) ratio of 4:1 for all experiments.
In figure 6 we demonstrate that CXCR4 dimerisation can be
monitored using both fluorescence anisotropy and FLIM imaging
in cells fixed at various time-points after treatment with CXCL12.
The plots represent the pooled image mean for ten images per
condition. At time zero the values of acceptor anisotropy (0.28 for
sensitised Tag-RFP) and donor lifetime values (2.0 ns) attest to the
fact that there are a low number of dimers prior to internalisation.
After 120 mins these values drop to 0.23 and 1.75 ns indicating an
increase in FRET efficiency upon treatment with the ligand.
Subsequently, we performed a small molecule screen with the
aim of identifying compounds blocking CXCR4 dimerisation.
In this mock experiment we used CXCR4 inhibitors alongside
kinase, receptor tyrosine kinase and GTPase inhibitors (figure 7A).
50 wells of the 96 well microplate were seeded with cells, each row
of the plate being internally controlled. The assay is performed
in the presence or absence of the CXCR4 ligand CXCL12 in
order to obtain a control measurement for each inhibitor. The
anisotropy and fluorescence lifetime data are summarised in
figure 7B which shows the pooled data for 5 images in each
modality for each condition. The colours of the data bars indicate
the treatment condition of each well (as shown in figure 7A).
To summarise the data, firstly, figure 7C shows that the ac-
ceptor anisotropy and FLIM data of cells in the absence of any
inhibitors (varying CXCL12 concentrations) are in agreement
showing the expected concentration-dependent increase in re-
ceptor dimerization (these data are displayed in column number
10 of the graphs of figure 7B). In this case we choose to convert the
lifetime data to FRET efficiency since a row-to-row variation
occurs in donor lifetime data. However, the inclusion of CXCR4-
eGFP only control wells within the row (column number 11 in
figure 7B) meant that a conversion to FRET efficiency could be
used to internally control for this effect. In the absence of the
acceptor construct CXCR4-TagRFP (i.e. CXCR4-eGFP only)
(column number 11 of figure 7B), we do not measure any FRET
by fluorescence acceptor anisotropy or FLIM as expected.
Furthermore, we find that all dedicated CXCR4 inhibitors (green
wells in figure 7A and 7B) are highly effective in blocking
dimerization as both the fluorescence acceptor anisotropy and
lifetime values do not drop below that of the untreated wells
(unstimulated controls). Those compounds proved to be at least
equally effective as the commercially available CXCR4 inhibitor
AMD3100. These findings are summarised in figure 7D which
plots the percentage change against the control wells for both the
anisotropy and lifetime data. This graph clearly shows which
compounds were effective in blocking CXCR4 internalisation.
The wells where a change in FRET efficiency upon treatment with
CXCL12 are clearly visible in these graphs. It is also clear that all
wells where the dedicated CXCR4 inhibitors were applied did not
show statistically significant changes in FRET, as compared to the
wells untreated with CXCL12. These wells can be easily identified
in either methodology. It should be noted that the numerical
values of the percentage changes are not the same in each meth-
odology. As discussed earlier, reductions in anisotropy and lifetime
are highly correlated, however the relationship between anisotropy
and FRET efficiency are highly non-linear and therefore we would
not expect percentage changes in anisotropy and lifetime to be
linear.
The dynamin inhibitor (dynasore) was used to test accumulation
of receptor dimers at the plasma membrane in the absence of
receptor internalization. Dynamin has been shown to be required
for the endocytosis of a number of receptors [67,68], including
that of GPCRs [69]. However, our measurements suffered from a
lack of correlation between the anisotropy and lifetime results due
to the dynasore compound being highly fluorescent (see figure S2).
The fluorescence which appears in the donor emission channel
causes a significant reduction in the measured fluorescence lifetime
for these wells (0.7 ns) but the measured anisotropy in the acceptor
channel is around 0.4. Figure S1 shows that in fact the compound
is distributed throughout the (glycerol based) mounting medium
which has effectively immobilised the molecules leading to the
high anisotropy value. Importantly, although producing spurious
data in the functional imaging modalities, we could conclude that
dynasore was ineffective in blocking receptor internalisation since
vesicle formation upon ligand treatment could clearly be visualised
in the wide-field intensity images (from which the anisotropy is
calculated).
Discussion
FLIM and Anisotropy Measurements of FRET are
Correlated
The FRET standard constructs provide us with positive and
negative controls for the biosensor assays. In the case of the
7 amino acid linker the eGFP and mRFP1 a calculation of the
Forster radius estimates the fluorophores to be within 5 nm: a
distance which is unlikely to be achieved in the case of a biosensor
Figure 3. Summary of FRET standard data. (A) Examples of histograms produced from functional images. Mean values from these images are
compared across the data set in screening experiments. (B) Plot of equation (2) showing a proposed means for converting sensitised emission
anisotropy to FRET efficiency. (C) Histograms from (A) after conversion to FRET efficiency. (D) Accumulated data from multiple regions of interest from
FRET standard imaging. Mean values from the functional images are plotted for each construct illustrating the scatter in the data. The average value
obtained for each construct is shown as a column plot.
doi:10.1371/journal.pone.0033231.g003
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Figure 4. A comparison FRET standard constructs to the baseline activity of Raichu and RhoA biosensors. (A) Anisotropy measurements
of Cdc42-Raichu biosensor stably transfected in A431 cells when the RFP acceptor is both directly and indirectly excited. The baseline activity of the
biosensor results in apparently depolarised sensitised emission with an average value of 0.12560.009 as compared to 0.26360.006 when directly
Multi-Functional Imaging in High-Content Screening
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molecule. The FRET efficiency of the 32AA construct appears
similar to the base-line activity of the biosensors, where the
construct would be in an inactive confirmation. It would appear,
then that in its inactive conformation the biosensor is not what we
could consider to be fully open. We can draw this conclusion since
the biosensor is a molecule of 3422.82 Daltons with a full length
which far exceeds the 32AA construct. To make a direct com-
parison to the Raichu biosensor would require a much longer
linker length, which would be unfeasible due to the flexibility of
the amino acid chain. Nevertheless, in a real assay these constructs
can be used to provide additional positive and negative controls.
Figure 2 illustrates that when the spatial information is retained
in the anisotropy the correlation with FLIM imaging data is
remarkably good. A pixel-by-pixel analysis is difficult since the
anisotropy data is obtained using a single CCD frame with the
microscope in epi-fluorescence mode and the FLIM image is
captured by laser scanning: the two modalities are not perfectly
registered due to the sampling and image magnification. However,
despite the anecdotal nature of the comparison it is clear that the
two modalities are very well correlated. Figure S1 shows an
analysis of the correlation on an image-by-image basis. Pearson’s
coefficient is calculated to be 0.75 (when discounting the eGFP
alone data) showing the two methodologies to be highly correlated.
This gives us confidence that an acceptor anisotropy measurement
will reproduce any variations in FRET efficiency that might arise
in the screening assays allowing subsequent quantification using
fluorescence lifetime measurements.
The estimation of FRET efficiency given in equation (2)
requires knowledge of the molar extinction coefficients for both
donor and acceptor molecules which, like the reference lifetime
of the donor fluorophore, are difficult to determine in-situ and
require calibration samples or a reliance on literature values. In
figure 3D, equation (2) is plotted using literature values of the
extinction coefficients and using absorption data obtained for
mRFP1 in neutral buffer [45] at the excitation wavelength
(490 nm) and measured values of donor anisotropy in the absence
of acceptor. The data points plotted consist of FRET efficiency,
determined using fluorescence lifetime measurements, plotted
against acceptor anisotropy for the FRET standard constructs. It
is clear that a very similar trend is achieved between equation 3
and the experimental data. However, fitting the data requires a
significant alteration of the mRFP1 extinction coefficient from the
spectroscopic data and literature values. It is interesting to note
that the absorption spectrum of mRFP1 contains a peak cor-
responding to absorption of immature or poorly folded protein
centred at approximately 500 nm. Given that this state does not
appear in the excitation spectrum and may vary dependent on
level of expression relative to the principle excitation peak, we
might reasonably assume that the calculated value for the mRFP1
extinction coefficient incorrect. This is somewhat unsurprising
since the equation suggested in [34] is really only applicable in
systems which are dynamically averaged (the incorrect assumption
being that the acceptor will fully depolarise within the lifetime of
the donor excited state). Additionally, the equation is poorly
behaved at the limits of low and high FRET efficiency and
inevitably produces an artificially broad histogram when convert-
ing anisotropy imaging data to FRET efficiency (Figure 3B). It is
clear that there are many unknown factors which prevent us
unambiguously converting acceptor anisotropy to FRET efficiency
and it is beyond the scope of this work to produce a theoretical
framework within which this could be done.
Figure 4 shows a comparison of the FRET standard constructs
with several Rho-GTPase biosensor constructs, all with eGFP as
the donor fluorophore and mRFP1 as the acceptor. Figure 4 A
and B directly compares the output from an acceptor anisotropy
measurement and a corresponding donor lifetime measurement
for the constructs. These data show that the correlation between
the two techniques is apparent for all the constructs tested. This
gave us the confidence that such an approach could be used in a
biosensor screen.
Cdc42-Riachu Biosensor Pseudo Screen
Figure 5 shows a comparison of fluorescence anisotropy and
lifetime data for a small-scale test screen of three TKIs against
Cdc42-Raichu. A431 cells were plated in 60 wells of 96 well plate
and five images per well were acquired in each modality. In this
experiment the anisotropy and lifetime did not exhibit as high a
correlation as observed in the previous data sets. This proved to be
due to a sample preparation dependence in the lifetime data which
was not reproduced in the acceptor anisotropy data. The inclusion
of the 19AA and 32AA constructs prove that the reduction in
lifetime seen in the Cdc42-Raichu data is not a result of addition of
the TKIs. These data show a gradual reduction in lifetime (and
so an increase in notional FRET efficiency) for all conditions
including the FRET standards and DMSO control. Clearly, since
the FRET standards are inactive they are not expected to be
affected by addition of the TKIs. Therefore the inclusion of two
modalities which we know to be highly correlated (as shown by
the FRET standard data given in figures 2 and 3) allows us to
effectively identify the presence of false positives and sample
preparation dependent effects in any FRET screen.
Previous experiments using high-resolution multi-photon FLIM
(data not shown) have suggested that the TKIs AG1478 and
PD168393 should produce an increase in Cdc42-Raichu activity
in this assay but this result was not recapitulated in this screen. We
performed additional live-cell FLIM experiments (figure S3) to
check the biosensor activity. Three clear phenotypes are seen in
these experiments. Those cells that are highly motile have a high
FRET efficiency indicating that the Cdc42-Raichu biosensor is
highly active. Cells undergoing mitosis also show high activity of
the probe. After division and as junctions are formed with other
cells biosensor activity reduces to something like baseline levels.
This provides compelling evidence for a lack of hits in the screen.
The samples are prepared such the cells are grown to a confluent
monolayer before fixation in order to provide good coverage of the
well. Although there is a proportion of cells where the probe was
highly active when fixation occurred, most of the cells in the image
are quiescent and therefore the biosensor is at baseline levels of
activity. It is clear that the experiment design needs modification
in order to find hits in this kind of screen. However, this does not
detract from the fact that the methodology of using a combination
of acceptor anisotropy and donor is very effective.
Acceptor Anisotropy Quantitatively Reports Protein-
protein Interaction
Where 1:1 donor:acceptor stoichiometry does not exist, as in the
CXCR4 assay the situation is complicated by the presence of
unbound donors and acceptors. This case where we have mixed
excited. (B) Plot of anisotropy values versus the percentage of the image pixels used in the calculation. This provides an extra metric by which outliers
can be removed from the data. (C) Fluorescence anisotropy imaging data. (D) Fluorescence lifetime imaging data. The error bars in both graphs
represent the pooled standard deviation of 3 images (in each modality) for each condition.
doi:10.1371/journal.pone.0033231.g004
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populations of FRET pair (CXCR4 dimers) and free donor and
acceptor molecules is similar to the p-FRET concept presented in
[70]. Here we do not follow Mattheyses et al. and produce an
estimate of the relative concentrations of the three populations
since we are interested only in whether CXCR4 internalisation,
and therefore dimerization, is inhibited. This is a fairly un-
ambiguous assay since binding of CXCL12 to CXCR4 produces
highly distinct vesicular structures. We seek to generate a readout
of this process without the need to examine whether these struc-
tures are produced but of course the fact that we have the images
available to us means we can always cross-check our result. In
other assays where the FRET pair does not undergo such obvious
translocation it would be necessary to pre-calibrate the assay such
that the fluorescence anisotropy of the donor, acceptor and FRET-
pair separately so that an accurate measure of the interaction is
produced. The lifetime data in figure 6 show that the FRET
efficiency is around 10% when dimers are formed upon inter-
nalization. It is important to note that the sensitivity of the an-
isotropy measurement is sufficient to give a robust readout even
in this assay. We were also able to reproduce the same hits un-
ambiguously using both wide-field and scanning methodologies.
The dedicated CXCR4 inhibitors could be identified by either
methodology and again each technique proved to be highly
correlated. We were also able to reproduce a concentration
dependence in the application of CXCL12 (Figure 6C).
In order to screen for potential inhibitors of CXCR4 it was
necessary to engineer a donor and acceptor expressing cell line as
a biosensor to determine the effect of a population of receptors
which is reproducible and effective across the cell population for a
variety of treatments. In this case, we do not measure a change in
FRET efficiency in the purest sense (since the interaction distance
between donor and acceptor is believed to be similar whether a
dimer is formed on the membrane or within a cellular vesicle).
Instead, we expect a change in the interacting population. In a cell
with uncontrolled levels of donor and acceptor this interacting
population may be determined in the case of fluorescence lifetime
imaging by attempting to fit biexponential models to the data
(thereby assuming only two populations: interacting and non-
interacting for the donor). In this case the comparison between
different cell populations (treated and untreated) becomes sig-
nificantly more complex since both the stoichiometry and the
interacting fraction must be known for each cell. Also the
calculation of FRET efficiency from a single exponential fit is
significantly more robust than a biexponential at low photon
counts. If we control the stoichiometry whilst maximising dynamic
range (increasing the probability of green-red dimer formation)
and maintaining function of the protein of interest, we have a
robust cell biosensor. In this case single cell clones containing
CXCR4- eGFP and CXCR4-TagRFP were screened for both
functionality and FRET efficiency with/without stimulation to
determine the best compromise between expression level and
FRET dynamic range (a 4:1 ratio was found to be near optimum).
In adapting this assay for other protein-protein interactions the
optimum stoichiometry must be determined through cloning, cell
sorting and screening operations for function and dynamic range.
It is clear that fluorescence anisotropy provides a fast metric which
can be used for hit finding in high-content screening assays. It
should be noted that although the FLIM images require sig-
nificantly longer acquisition times they still not prohibitively long.
Should lifetime data be required for the entire microwell plate,
as in the assays presented here, the experiment can simply be
performed overnight or through the course of several days since
the microscope platform can run completely unsupervised. With
advances in detection technology and more advanced data fitting
routines these acquisition times will improve dramatically. New
Figure 5. Direct comparison between (A) acceptor FA and (B) donor FLIM when screening TKIs against the Cdc42-Riachu Biosensor.
The error bars in both graphs represent the pooled standard deviation of 5 images (in each modality) for each condition.
doi:10.1371/journal.pone.0033231.g005
Figure 6. Time course data showing the change in FRET
efficiency that occurs upon the internalisation of CXCR4 after
treatment with CXCL12. (A) Column plots for acceptor anisotropy
and donor FLIM for each time point (average of ten images per time
point). The error bars represent the pooled standard deviation from
multiple images (B) Example functional images showing change in FRET
efficiency upon interalization and correlation between the two imaging
techniques. (Scale bars represent 50 mm.)
doi:10.1371/journal.pone.0033231.g006
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Figure 7. Summary of small molecule inhibitor screening data of CXCR4. (A) Layout of microplate. Wells marked in green are CXCR4
inhibitors. Controls are shown in white: column 10 shows data for CXCR4-eGFP and CXCR4-TagRFP transfected cells without inhibitor treatment;
column 11 shows CXCR4-eGFP only cells without inhibitor treatment. In column 10 the concentration of CXCL12 is varied: row D is untreated while
rows E and F are treated with 5 nM and 20 nM CXCL12 respectively. (B) Comparison of anisotropy and lifetime data showing that dimerisation and
internalisation is blocked by CXCR4 inhibitors. Errors bars represent the standard deviation of repeated measurements in each well (4 images per well
for each modality). (C) Plots of anisotropy and FRET efficiency for column 10, rows D, E and F: cells in the absence of any inhibitors (CXCL12
concentrations of 5 nM and 20 nM). (D) Percentage change in anisotropy and lifetime compared to controls.
doi:10.1371/journal.pone.0033231.g007
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hybrid detectors available from Hamamatsu provide significant
improvements in sensitivity and should reduce acquisition times
(for the same number of collected photons) by at least 50 percent.
The application of Bayesian or maximum likelihood statistics to
data fitting will reduce the number of photons required to de-
termine the fluorescence lifetime. Preliminary studies suggest that
acquisition times could be reduced to less than one minute per
image making lifetime imaging a viable screening methodology in
its own right. Here we have applied the two techniques in FRET
assays using a low NA microscope objective lens so that we could
collect data from a statistically significant number of cells. The
techniques could equally apply in a situation where high-spatial
resolution, and therefore high NA lenses would be required (such
as measurement of FRET within microdomains). However, there
is a caveat to be considered in the case of fluorescence anisotropy:
high NA lenses result in a depolarisation of the fluorescence
emission and, therefore, must be considered. A correction for de-
polarisation is easily calculated and has been published previously
by Axelrod et al [71].
Materials and Methods
Plasmids, Cell Lines, and Cell Culture Conditions
mRFP-eGFP FRET standards were constructed by the ligation
of mRFP1 into the pEGFP-N1 vector used in the manufacture of
the Raichu biosensor constructs, generating random amino acid
linkers. The linker for the 7 AA sequence is RDPPVAT, for the
19AA sequence is KLRILQSTVPRARDPPVAT, and that for the
32AA sequence is KLRILDITSGLETRDASGQSTVPRARDPP-
VAT. These constructs were expressed transiently in human
embryonic kidney (HEK)-293T cells [72] obtained from the
American Type Culture Collection (ATCC).
Raichu probes for reporting the spatial activity of small Rho
GTPases, obtained from Prof M. Matsuda (Osaka University,
Japan), were modified from their original form to replace the
YFP/CFP fluorophores with eGFP/mRFP1 such that the probe
can be used in fluorescence lifetime imaging [24]. The resultant
GFP- and mRFP1-tagged Raichu constructs retain the original
design of the CFP/YFP-tagged version i.e. mRFP1-PBD-GTPase-
GFP12. The sensor was synthesized by excision of the module
between YFP and CFP and insertion between the mRFP1 and
eGFP (in the pEGFP-N1 vector (Clonetech), modified by the
addition of mRFP1 and altering the multiple cloning site). The
membrane targeting CAAX sequence was added after the eGFP.
A431 human epidermoid cancer cell lines [73] (obtained from the
ATCC) were generated stably expressing the Cdc42 variant of the
biosensor and Cdc42-eGFP to provide a donor-only control.
The chemokine receptor CXCR4 was fused with its C-terminus
via a short linker to the N-terminus of either GFP or TagRFP as
described earlier [66,74]. Briefly, constructs were obtained by sub-
cloning the human CXCR4 coding sequence into the HindIII and
EcoRI sites of pEGFP-N1 (Clontech) or pTagRFP-N1 (Evrogen),
followed by further sub-cloning into the retroviral expression
vectors pLPCX or pLHCX (both from Clontech), and verification
by sequencing. MTLn3E mammary rat carcinoma cells [75] (a
kind gift of Dr Erik Sahai (London Research Institute, Lincoln’s
Inn Fields)) stably expressing human CXCR4-eGFP were
obtained after retroviral infection, selection with puromycine
(2 mg/mL), and fluorescence-activated cell sorting (FACS) in order
to obtain single clones. A cell line expressing both fluorescent
proteins was generated via sequential retroviral infection with
pLPCX CXCR4-eGFP and pLHCX CXCR4-TagRFP, selection
and FACS-based single clone sorting. One single clone of each cell
line was selected and used for all further experiments.
All clones were cultured in aMEM supplemented with 5% fetal
bovine serum, penicillin/streptomycin (100 IU/0.1 mg/mL), and
L-glutamine in an atmosphere containing 5% CO2/95% air (v/v)
in the presence of the respective selection antibiotics (0.5 mg/mL
puromycin and/or 200 mg/mL hygromycin).
Reagents
Recombinant CXCL12 was obtained from Peprotech and
generally used at 100nM (unless otherwise indicated). The
following kinase inhibitors were purchased from Calbiochem
(targets in brackets): Ro32-0432 and Go¨6979 (both protein kinase
C); SB203580 and SC409 (p38 MAP kinase); SL327 (MEK1 and
MEK2 kinases); PP2 (SRC kinase); wortmannin (phosphatidyli-
nositol-3-kinase); Y27632 (Rho associated protein kinases); Akt-
VIII (AKT1 and AKT2 kinases); dynasore (GTPase activity of
dynamin1/2); AG1478, PD168393 and Genistein (EGFR receptor
tyrosine kinase); 4557W (EGFR and ErbB2 receptor tyrosine
kinases); c-MetIII (c-MET receptor tyrosine kinase). The bicyclam
compounds CuCB, CuCB-OAc, CuCB-Cl, ZnCB, and CuSB
were kind gifts of SJ Archibald and are intended to inhibit
CXCR4 [76,77]. The CXCR4 inhibitor AMD3100 and Pertussis
Toxin (PT) were from Sigma.
Sample Preparation for Imaging
For anisotropy and/or FLIM experiments cells were plated
either onto glass cover slips (No.1.5, Mentzel) or into black glass-
bottom 96-well microplates (Greiner). All glass surfaces were acid-
washed (40% (v/v) conentrated HCl in ethanol) and sterilized
before cell seeding. If desired, sub-confluent cells were pre-treated
with inhibitors or toxins at the indicated concentrations for 60 min.
Cells were treated with CXCL12 as indicated (100 nM, unless
stated otherwise), fixed with 4% (w/v) paraformaldehyde at room
temperature for 15 min, permeabilized with 0.25% (v/v) Triton
X-100 in PBS for 10 min, treated with 1 mg/mL NaBH4 in PBS
for 5 min, rinsed with PBS, and mounted in MOWIOL con-
taining 2.5% (w/w) DABCO as antifading agent.
Automated Microscopy
The combined fluorescence lifetime and fluorescence anisotropy
microscopy system has been described elsewhere (recent publica-
tions by Matthews et. al [25], Barber et al [78]) and online (http://
users.ox.ac.uk/˜atdgroup) but in brief:
The microscope has two, user selectable, modes of operation.
An epi-fluorescence microscope is constructed using off-the-shelf
optical elements into which is coupled the output from a halide
lamp using a liquid light guide (Intensilight, Nikon Instruments,
Japan). To achieve anisotropy imaging the output from the lamp is
passed through a linear polariser and half-wave plate. Fluores-
cence is detected via a QuadView polarisation resolved image
splitter (Photometrics) which collects light in two orthogonal
polarisation channels at wavelengths of 515630 nm and
630670 nm (filters obtained from Chroma Technologies, Rock-
ingham, VT, U.S.A.); wavelengths which have been selected for
the detection of eGFP and mRFP1. In a single CCD exposure we
obtain four spatially identical images, which differ according to
their wavelength and polarisation content. The four sub-images
are extracted and used to calculate fluorescence anisotropy of the
donor and acceptor fluorophores. To enable automated operation
we include a motorised stage (Ma¨rzhauser GmbH, Wetzler,
Germany), a closed-loop objective lens mount with a 500mm range
of travel (Piezosystem Jena GmbH, Jena, Germany), and a
motorized filter cube selector. The system is controlled using an
integrated modular software package developed providing the user
with the ability to control every aspect of image acquisition
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including access to the Python scripting language for complete
automation of an assay or screen. Currently, post-acquisition
image processing is performed off-line using ImageJ and
MATLAB.
An afocal dual axis scanning system and time-correlated single
photon counting (TCSPC) detection (SPC830, Becker and Hickl)
is incorporated to enable fluorescence lifetime imaging. Fluores-
cence excitation is provided by a 473 nm emitting laser diode
(BDL-473_SMC, Becker and Hickl) which generates optical pulses
with a duration of 40 ps at a repetition rate of 80 MHz. Single
photon, time-resolved detection is achieved using a photomulti-
plier tube (PMH-100, Becker and Hickl) filtering for the
fluorescence with a 510630 nm bandpass filter for eGFP. To
avoid pulse pile up and to ensure photobleaching is kept to a
minimum count rates are maintained at less than 16105 events per
second.
FLIM by TCSPC does not achieve the imaging speed of wide-
field frequency domain systems but is the gold-standard for
lifetime imaging due to its accuracy and time-resolution. It is for
this reason, and given our previous experience with such meth-
odologies, that we incorporate lifetime imaging using TCSPC into
our automated platform. With the current instrumentation an
entire 96-well microplate can be screened in around five hours
(depending on how many images per well are captured and on
sample brightness), which means that the imaging can be per-
formed unsupervised overnight. In our strategy it is the aim to use
the lifetime imaging as a high time resolution method for cross-
checking our fast wide-field technique. However, the time-taken is
in fact not prohibitively slow. Efforts are underway, from a data-
analysis point of view, to incorporate Bayesian or maximum
likelihood techniques [79] to allow the number of photons re-
quired to achieve a reliable fit to the data to be relaxed and as such
it would be possible to speed up the acquisition of TCSPC data by
at least a factor 3. Additionally highly sensitive detection tech-
nology has recently become available which significantly improves
acquisition times for TCSPC-FLIM.
Calculation of Acceptor Anisotropy
Processing of images from the wide-field component of the
instrument was performed using bespoke software written in
Matlab (The Mathworks, Natick, MA). The raw 134461024 pixel
CCD images are saved in the Image Cytometry Standard (ICS), a
format which is capable of storing multi-dimensional data, in any
numeric format along with image history or meta-data. Impor-
tantly for our purposes, the 12-bit images acquired from the
camera can be stored in the ICS image and the resulting an-
isotropy image calculated from these raw images can be saved as
floating point numbers within the same image format. Keeping a
consistent image format allows both raw and functional images to
be displayed by the same image processing and viewing software
packages (typically ImageJ and IrfanView which both support the
ICS format).
Post acquisition the raw images are split into four separate sub-
images corresponding to two wavelength channels in two or-
thogonal linear polarisation directions (an example of a pre-split
image is given in Figure S4). Next the sub-images are registered in
each wavelength channel. Two methods are available: the first is a
manual routine where fiducial markers are identified in each
image being registered and a projective 2-D transform is applied.
The second method is an automated routine [80] which does not
require user input, useful if obvious fiducial markers cannot be
identified or a calibration image was not acquired. This routine is
a rigid-body image registration performed using a cross-correla-
tion technique which determines image rotation and pixel offset
but not shear or scale (unnecessary in this case since the system
does not suffer from significant chromatic aberration). A mutual
information joint entropy matrix is computed for the input images
and maximized using Powel’s direction set method [81]. The
calculation can take a few minutes to execute but needs only be
performed at the start of the image analysis process and needs only
be run if the set-up of the microscope is changed by the user. The
registration parameters are saved to a transformation file and can
be called upon by the user when processing large batches of
images recorded with the same microscope configuration. Since
the reproducibility and reliability of the fluorescence anisotropy
calculation is highly dependent on the signal-to-noise ratio in each
pixel [82] the batch processing software allows a Gaussian
convolution filter and masking routine to be implemented. A user
definable rigid background subtraction, based on an intensity
threshold, is also implemented in the software.
The fluorescence anisotropy for each voxel in each of the two





Here Ivv and Ivh represent the fluorescence emission intensities
measured parallel and perpendicular, respectively, for the case
where the linear polarization of the excitation is oriented
vertically. In a microscope set-up the differences in efficiencies in
detecting light in orthogonal polarisation directions is accounted







Analysis of Fluorescence Lifetime Data
Here we give a brief summary of the processing and analysis of
time-resolved images acquired by TCSPC using the modified
Levenberg-Marquardt (MLM) algorithm [83] which has been
implemented in a software package called Time Resolved Imaging
(in its second major release called TRI2 available upon request
from P Barber) [84]. The photon counts in each pixel of the image
are binned by the ADC of the counting electronics and it is these
photons that are used to determine the fluorescence lifetime in
each pixel allowing the construction of a so-called time-resolved
image. Although initially not designed with high-content screening
in mind, the software provides the means to perform these
calculations for large batches of images. The calculations can be
done in a number of ways with the most recent release providing a
means for performing global analysis on time-domain data [85].
The software attempts to fit a model similar to that given in
equation (2) by iterative re-convolution (a mono-exponential fit is
achieved by setting a2 = 0). The quality of the fit is judged using
the reduced x2r parameter, as given by equation (4). x
2
r is
minimised using the MLM algorithm. The key to the speed which
the algorithm achieves is the rapid lifetime determination (RLD)
method which is used to provide parameter estimates for the
fitting; details can be found in [84,86,87]. The images can be
processed on a pixel-by-pixel basis, where each image is treated as
completely independent (for large batches the same initial
parameters are applied to each image in turn) or the fitting can
be done using global analysis where selected images, or indeed the
entire dataset, can be fitted simultaneously.
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In the above I0 is the peak intensity; a1 and a2 are the fractional
proportions of the lifetimes t1 and t2 respectively. Iinstr(t) is the
instrument response function. I(tk) is the data and Ic(tk) is the fit at
time point k. n is the number of time points and p is the number of
variable fit parameters. An example of lifetime data, and the fit
generated, for a 565 group of pixels for an image of the 7AA
FRET standard is given in Figure S5.
Supporting Information
Figure S1 Shows a plot of lifetime against anisotropy
extracted on an image-by-image basis for each of the
FRET standard constructs. A calculation of Pearson’s
coefficient shows the two methods of measuring FRET are highly
correlated. If the GFP data is not included we calculate a
coefficient of 0.75.
(TIF)
Figure S2 A wide-field image of MTLn3E expressing
CXCR4-eGFP and CXCR4-TagRFP after addition of
CXCL12 for one hour and treatment with the dynamin
inhibitor dynasore. This image illustrates the origin of the lack
of correlation between acceptor anisotropy and donor lifetime
measurements. Dynasore is fluorescent and has a spectrally broad
emission spectrum causing it to appear in both the eGFP and Tag-
RFP channels. The appearance in the eGFP donor channel
produces an average lifetime in these wells of around 0.7 ns. The
wide-field image shown here illustrates that the dynasore is
distributed throughout the glycerol mounting medium and this
directly results an average anisotropy of around 0.39 in the
acceptor channel.
(TIF)
Figure S3 This montage shows twelve frames extracted
from a live cell FLIM image sequence that was recorded
over the course of twenty hours. Each frame is separated by
twenty minutes. The sequence shows the variation in Cdc42-
Raichu activity. We see three clear different types of behaviour in
this sequence. The red arrow indicates a cell which undergoes
mitosis in the time-frame of the sequence. Initially Cdc42-Raichu
activity is high (as indicated by the redder colours on this look-up-
table) which then decreases when the two daughter cells spread
and become part of the surrounding group of cells. The cell
indicated by the white arrow is highly motile and has a cor-
respondingly high Cdc42-Raichu activity. As the sequence
proceeds the cell becomes less motile and eventually forms a
junction with surrounding cells. This process correlates with a
gradual reduction in the level of Cdc42-Raichu activity (as
evidenced by the colours becoming bluer indicating an increase in
fluorescence lifetime). Those cells that formed junctions before the
sequence began remain in this state throughout the sequence and
Cdc42-Raichu activity also remains low. (Scale bars represent
50 mm.)
(TIF)
Figure S4 An example of a wide-field image which is
divided into four spatially identical regions which differ
in their wavelength and polarisation content. The image is
divided into two wavelength channels and two orthogonal
polarisations.
(TIF)
Figure S5 An example of a fit to donor fluorescence
lifetime data using the software package TRI2. The data
is a 565 pixel region that has been extracted from an image of a
Hela cell expressing a FRET standard with a 7AA linker. The data
is fitted using the Levenburg-Marquardt algorithm within TRI2
using both a mono- and bi-exponential model. The residuals and
x2 values indicate the quality of the fit. There is a slight im-
provement when using a bi-exponential fit over the mono-
exponential case but we chose to use the simpler model
throughout since the fit has a x2 value around 1.0. When con-
structing FLIM data the image is first processed using a block
processing routine with a circular kernel and then each pixel in the
2566256 image is fitted as described here.
(TIF)
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